Pegylated liposomal doxorubicin for epithelial ovarian cancer: The utility of Ca125 trends in guiding treatment decisions and subsequent response to platinum retreatment

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 26; no. 15_suppl; p. 16539
Main Authors Tanguay, J. S., Buckley, L., Hussain, S. A., Fernando, I. N.
Format Journal Article
LanguageEnglish
Published 20.05.2008
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2008.26.15_suppl.16539